Rankings
▼
Calendar
VERA (Vera Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
VERA
Vera Therapeutics, Inc.
Mkt Cap
$3B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$300M
EPS (TTM)
-$4.66
Free Cash Flow (TTM)
-$242M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$506K
-$31M
Q2 23
$0
$0
-$22M
Q3 23
$0
$0
-$22M
Q4 23
$0
$635K
-$27M
Q1 24
$0
$952K
-$31M
Q2 24
$0
$0
-$37M
Q3 24
$0
$0
-$50M
Q4 24
$0
$0
-$49M
Q1 25
$0
$0
-$57M
Q2 25
$0
-$563K
-$80M
Q3 25
$0
-$564K
-$84M
Q4 25
$0
$1M
-$94M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$26M
-$26M
Q2 23
-$18M
-$18M
Q3 23
-$23M
-$23M
Q4 23
-$25M
-$25M
Q1 24
-$34M
-$34M
Q2 24
-$25M
-$25M
Q3 24
-$37M
-$62M
Q4 24
-$39M
-$40M
Q1 25
-$54M
-$55M
Q2 25
-$55M
-$55M
Q3 25
-$62M
-$62M
Q4 25
-$70M
-$70M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$63K
Q1 24
$0
Q2 24
$89K
Q3 24
$25M
Q4 24
$645K
Q1 25
$187K
Q2 25
$208K
Q3 25
$133K
Q4 25
$102K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+83.6%
Q2 23
—
+45.9%
Q3 23
—
-13.8%
Q4 23
—
-19.5%
Q1 24
—
-0.5%
Q2 24
—
+70.0%
Q3 24
—
+128.9%
Q4 24
—
+81.0%
Q1 25
—
+83.8%
Q2 25
—
+114.6%
Q3 25
—
+68.5%
Q4 25
—
+92.6%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
—
Q2 23
$3M
—
Q3 23
$3M
—
Q4 23
$0
—
Q1 24
$4M
—
Q2 24
$5M
—
Q3 24
$6M
—
Q4 24
$6M
—
Q1 25
$8M
—
Q2 25
$9M
—
Q3 25
$10M
—
Q4 25
$11M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$26M
—
—
$6M
Q2 23
$16M
$6M
—
—
Q3 23
$16M
$6M
—
—
Q4 23
$22M
$6M
—
—
Q1 24
$25M
$8M
—
—
Q2 24
$29M
$8M
—
—
Q3 24
$40M
$9M
—
—
Q4 24
$33M
$16M
—
—
Q1 25
$41M
$15M
$1M
—
Q2 25
$58M
$22M
—
—
Q3 25
$56M
—
—
$27M
Q4 25
$60M
$35M
—
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$137M
$60M
$197M
Q2 23
$34M
$147M
$181M
Q3 23
$27M
$132M
$160M
Q4 23
$46M
$115M
$161M
Q1 24
$69M
$335M
$404M
Q2 24
$25M
$359M
$384M
Q3 24
$27M
$326M
$353M
Q4 24
$93M
$548M
$641M
Q1 25
$55M
$535M
$590M
Q2 25
$49M
$508M
$557M
Q3 25
$58M
$440M
$497M
Q4 25
$355M
$715M
$1.1B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
38M
+35.5%
Q2 23
44M
+17.5%
Q3 23
44M
+0.2%
Q4 23
44M
+0.2%
Q1 24
51M
+14.7%
Q2 24
55M
+7.4%
Q3 24
55M
+0.3%
Q4 24
55M
+0.0%
Q1 25
64M
+16.0%
Q2 25
64M
+0.2%
Q3 25
64M
+0.1%
Q4 25
64M
+0.6%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 19
—
—
FY 20
—
—
FY 21
$0
17
FY 22
$0
46
FY 23
$0
51
FY 24
$0
112
FY 25
$0
75K
marketcaparena.com